Advantage Solutions vs CoStar
ADV and CSGP side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ADV and CSGP compare
CoStar is the larger company, worth 30 times as much as Advantage Solutions ($12.2B against $409M).
CoStar grew revenue faster over the last twelve months (20.2% versus 2.9% for Advantage Solutions).
CoStar keeps more of each dollar of sales as profit, with a net margin of 4.9% compared with −8.9% at Advantage Solutions.
CoStar scores higher on the StockData Score (14 against 5 for Advantage Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ADV | CSGP |
|---|---|---|
| Size and price | ||
| Market cap | $409M | $12.2B |
| Share price | $31.92 | $30.27 |
| Change, 1 year | 0.54% | −55.0% |
| Change, 5 years | −83.7% | −62.9% |
| Beta (5Y) | 1.20 | 1.04 |
| Employees | 73K | 8,000 |
| StockData Score | ||
| Total score | 5 | 14 (better) |
| Valuation score | 3 | 4 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 68.8× |
| P/S | 0.1× (better) | 3.3× |
| P/B | – | 1.5× |
| EV/EBITDA | 32.6× | 22.7× (better) |
| P/FCF | 3.9× (better) | 28.9× |
| FCF yield | 25.6% (better) | 3.5% |
| Fair value | $155.29 | $33.81 |
| Margin of safety | 79.4% (better) | 10.5% |
| Growth | ||
| Revenue growth (TTM) | 2.9% | 20.2% (better) |
| Revenue growth, 5Y average | 2.3% | 14.4% (better) |
| Net income growth (TTM) | – | 791% |
| EPS growth (TTM) | – | 780% |
| EPS growth, 5Y average | – | −49.2% |
| Profitability | ||
| Gross margin | 13.1% | 78.3% (better) |
| Operating margin | −4.1% | 5.8% (better) |
| Net margin | −8.9% | 4.9% (better) |
| FCF margin | 2.9% | 11.5% (better) |
| Return on equity | – | 2.2% |
| Return on invested capital | – | 2.0% |
| Financial health | ||
| Debt / equity | – | 0.12 |
| Net debt / EBITDA | 25.22 | 0.89 (better) |
| Interest coverage | −1.0× | 7.3× (better) |
| Current ratio | 1.81 (better) | 1.32 |
| Altman Z-score | −0.16 | 3.67 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | 4.7% | 8.6% (better) |
| Shareholder yield | 4.7% | 8.6% (better) |
| Ownership | ||
| Held by institutions | 32.5% | 103% |
| Held by insiders | 68.3% | 1.3% |
| Insider net buying, 12 months | $368K | $8.2M (better) |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 15.0% | 3.1% |
Go deeper
- ADV stock overview
- ADV income statement
- ADV valuation and score
- CSGP stock overview
- CSGP income statement
- CSGP valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.